PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Symptom | |depression |
| Sentences | 81 |
| PubMedID- 23653854 | In this paper, we will review the epidemiology, course, impact, pathogenesis, and diagnostic assessment of depression in patients with cardiovascular disease (cvd). |
| PubMedID- 26278479 | In a recent meta-analysis of major depressive disorder (mdd) and hrv, kemp et al.2 reveal that unmedicated depression without cardiovascular disease (cvd) is associated with decreased vagal (parasympathetic) tone, as indexed by reduced hrv. |
| PubMedID- 25653245 | Glucose levels may predict depression in patients with cardiovascular diseases. |
| PubMedID- 20859545 | Absolute contraindications to β-blockers are severe or advanced bradycardia, conduction system disease (sinus node dysfunction and/or high-grade av block), asthma, peripheral vascular disease (pad) with rest ischemia, depression, and overt heart failure (hf). |
| PubMedID- 24944535 | People suffering from depression are being diagnosed with cardiovascular diseases significantly more often in comparing to general population and it is believed that cardiovascular diseases are being diagnosed ten years after the first depression episode (6). |
| PubMedID- 24039506 | How should we treat depression in patients with cardiovascular disease. |
| PubMedID- 24931717 | Cardiovascular disease risk factors associated with depression among korean adults with coronary artery disease and cerebrovascular disease. |
| PubMedID- 24307378 | Nevertheless, depression in patients with cardiovascular disease is not only associated with clinical outcomes, but also with adherence and poorer health status and impairments to quality of life independent of disease severity . |
| PubMedID- 23381649 | Of particular note are the high rates of premature death due to cardiovascular disease in persons with depression and the prevalence of metabolic syndrome in those receiving treatments for major mood disorders. |
| PubMedID- 24166703 | In adjusted analyses phobia comorbid with depression was associated with cerebrovascular disease (odds ratio (or) 1.61; 95 % confidence interval (ci) 1.04-2.50) as was panic disorder (or 2.89; 95 % ci 1.47-5.69). |
| PubMedID- 25439033 | Adjusted odds ratios for depression rose monotonically with number of cardiovascular disease (cvd) risk factor from 1.46 (95% ci, 1.18-1.75) for those with one risk factors to 4.36 (95% ci, 2.47-7.70) for those with five risk factors. |
| PubMedID- 23293051 | Background and objectives: depression in patients with cardiovascular disease (cvd) is extremely common, with a prevalence of 17-47%, and is associated with increased risk of morbidity and mortality. |
| PubMedID- 24649359 | Therefore, other important instruments which are often used in the clinical practice to evaluate depression in patients with cardiovascular disease may have been left out. |
| PubMedID- 24392265 | Evidence reveals that both psychotherapeutic treatment (eg, cognitive-behavioral therapy) and pharmacologic treatment (eg, use of the selective serotonin reuptake inhibitor sertraline) are safe and effective in reducing depression severity in patients with cardiovascular disease. |
| PubMedID- 23672522 | Generally, more specific states (for example, depression in association with late-life vascular disease; first episode psychosis; cannabis-associated recurrence of psychosis; depressive episode following previous manic episode) provide a better fit with known risk factors, actual pathophysiology or known illness course and may be much more useful in research and some fields of clinical practice . |
| PubMedID- 23611535 | Persistence of subsyndromal residual symptoms after remission of major depression in patients without cardiovascular disease may condition maintenance of elevated platelet factor 4 and beta-thromboglobulin plasma levels. |
| PubMedID- 26509854 | Hypothesis: suboptimal physical health status and anxiety or depression increase the risk of cardiovascular diseases. |
| PubMedID- 25910599 | depression in cardiovascular disease: from awareness to action. |
| PubMedID- 20153471 | It is also possible that the underlying pathology linking depression with cardiovascular disease (cvd) is specific to the coronary vessels. |
| PubMedID- 26106530 | Moreover, both hypertension and depression increase the risk of incident cardiovascular disease (cvd) and accelerate the progression of cvd (nemeroff and goldschmidt-clermont, 2012; thayer and lane, 2007). |
| PubMedID- 23410093 | Multivariable logistic regression was used to determine the relative odds of clinical cardiovascular disease in individuals with depression compared to those without depression. |
| PubMedID- 22216404 | In the women's health initiative, women with depression but no history of cardiovascular disease were not at increased risk of stroke, whereas those with a history of prior cardiovascular disease were at 45% increased risk of stroke . |
| PubMedID- 20494595 | Sleep duration, sleep continuity, and depression are associated with cardiovascular disease and metabolic disorders. |
| PubMedID- 25640936 | A new role for nortriptyline in depression associated with vascular disease. |
| PubMedID- 24769297 | Background: dietary habits and depression are associated with cardiovascular disease risk. |
| PubMedID- 20431233 | These findings generally support the hypothesis that—as is the case in western populations—anger suppression and depression increase the risk of cardiovascular disease among japanese. |
| PubMedID- 22783311 | , it has been shown there is a distinct connection between depression and increased risk of cardiovascular disease. |
| PubMedID- 23567371 | Background: depression was positively associated with cardiovascular disease (cvd) or mortality in previous studies. |
| PubMedID- 21042323 | These individuals, with mental health conditions such as schizophrenia, bipolar disorder and disabling depression, die primarily of cardiovascular disease. |
| PubMedID- 21960687 | Aims: depression often coexists with cardiovascular disease, such as hypertension and heart failure, in which sympathetic hyperactivation is critically involved. |
| PubMedID- 23630509 | The bdi is a reliable and well-validated measure of depressive symptomatology (beck et al., 1988), and is a widely used self-report measure of depression in patients with cardiovascular disease. |
Page: 1 2